DOSTARLIMAB-GXLY for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 134 adverse event reports in the FDA FAERS database where DOSTARLIMAB-GXLY was used for Product used for unknown indication.
Most Reported Side Effects for DOSTARLIMAB-GXLY
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 51 | 10.1% | 4 | 6 |
| Rash | 42 | 8.3% | 1 | 11 |
| Death | 28 | 5.6% | 28 | 1 |
| Malignant neoplasm progression | 28 | 5.6% | 4 | 2 |
| Fatigue | 22 | 4.4% | 2 | 4 |
| Neuropathy peripheral | 20 | 4.0% | 0 | 0 |
| Pyrexia | 20 | 4.0% | 0 | 9 |
| Product use in unapproved indication | 19 | 3.8% | 3 | 7 |
| Thrombocytopenia | 16 | 3.2% | 2 | 7 |
| Hypothyroidism | 14 | 2.8% | 1 | 3 |
| Erythema | 13 | 2.6% | 0 | 0 |
| Colitis | 12 | 2.4% | 0 | 5 |
| Dyspnoea | 12 | 2.4% | 3 | 2 |
| Diarrhoea | 11 | 2.2% | 1 | 6 |
| Pain | 11 | 2.2% | 2 | 2 |
Other Indications for DOSTARLIMAB-GXLY
Endometrial cancer (191)
Endometrial adenocarcinoma (33)
Endometrial cancer metastatic (33)
Uterine cancer (26)
Rectal cancer (14)
Endometrial cancer recurrent (10)
Endometrial cancer stage iv (9)
Endometrial neoplasm (6)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)